399 related articles for article (PubMed ID: 26277738)
61. Persistent dizziness after surgical treatment of vertigo: an exploratory study of prognostic factors.
Teufert KB; Berliner KI; De la Cruz A
Otol Neurotol; 2007 Dec; 28(8):1056-62. PubMed ID: 18084816
[TBL] [Abstract][Full Text] [Related]
62. Clinical indicators useful in predicting response to the medical management of Meniere's disease.
Devaiah AK; Ator GA
Laryngoscope; 2000 Nov; 110(11):1861-5. PubMed ID: 11081600
[TBL] [Abstract][Full Text] [Related]
63. Trends in the diagnosis and the management of Meniere's disease: results of a survey.
Kim HH; Wiet RJ; Battista RA
Otolaryngol Head Neck Surg; 2005 May; 132(5):722-6. PubMed ID: 15886625
[TBL] [Abstract][Full Text] [Related]
64. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
[TBL] [Abstract][Full Text] [Related]
65. People with symptoms of Ménière's disease: the relationship between illness intrusiveness, illness uncertainty, dizziness handicap, and depression.
Arroll M; Dancey CP; Attree EA; Smith S; James T
Otol Neurotol; 2012 Jul; 33(5):816-23. PubMed ID: 22705835
[TBL] [Abstract][Full Text] [Related]
66. [Simultaneous triple semicircular canal plugging and cochlear implantation in advanced Meniere's disease].
Zhang DG; Xu L; Han YC; Lyu YF; Luo JF; Li YW; Wang RJ; Fan ZM; Wang HB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 52(1):25-30. PubMed ID: 28104012
[No Abstract] [Full Text] [Related]
67. Prognostic implications of and audiometric evidence for hearing fluctuation in Meniere's disease.
Hoa M; Friedman RA; Fisher LM; Derebery MJ
Laryngoscope; 2015 Dec; 125 Suppl 12():S1-12. PubMed ID: 26343803
[TBL] [Abstract][Full Text] [Related]
68. One-third of vertiginous episodes during the follow-up period are caused by benign paroxysmal positional vertigo in patients with Meniere's disease.
Taura A; Funabiki K; Ohgita H; Ogino E; Torii H; Matsunaga M; Ito J
Acta Otolaryngol; 2014 Nov; 134(11):1140-5. PubMed ID: 25166020
[TBL] [Abstract][Full Text] [Related]
69. [Extratympanic electrocochleography in Ménière's disease].
Martín-Sanz E; Esteban Sánchez J; González Juliao M; Zschaeck Luzardo C; Mato Patino T; Rodrigañez Riesco L; Sanz Fernández R
Acta Otorrinolaringol Esp; 2012; 63(6):421-8. PubMed ID: 22682654
[TBL] [Abstract][Full Text] [Related]
70. Diuretic and diet effect on Menière's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines.
Santos PM; Hall RA; Snyder JM; Hughes LF; Dobie RA
Otolaryngol Head Neck Surg; 1993 Oct; 109(4):680-9. PubMed ID: 8233504
[TBL] [Abstract][Full Text] [Related]
71. What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.
Gürkov R; Pyykö I; Zou J; Kentala E
J Neurol; 2016 Apr; 263 Suppl 1():S71-81. PubMed ID: 27083887
[TBL] [Abstract][Full Text] [Related]
72. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
Kasemsuwan L; Jariengprasert C; Chaturapatranont S
J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
[TBL] [Abstract][Full Text] [Related]
73. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
74. Evolution of audiometric pattern in Meniere's disease: long-term survey of 380 cases evaluated according to the 1995 guidelines of the American Academy of Otolaryngology-Head and Neck Surgery.
Savastano M; Guerrieri V; Marioni G
J Otolaryngol; 2006 Feb; 35(1):26-9. PubMed ID: 16527013
[TBL] [Abstract][Full Text] [Related]
75. Clinical value of tone burst vestibular evoked myogenic potentials at threshold in acute and stable Ménière's disease.
Osei-Lah V; Ceranic B; Luxon LM
J Laryngol Otol; 2008 May; 122(5):452-7. PubMed ID: 17605832
[TBL] [Abstract][Full Text] [Related]
76. Intratympanic lidocaine instillation for Menière's disease.
Verdonck J; Desloovere C
B-ENT; 2011; 7(3):157-64. PubMed ID: 22026134
[TBL] [Abstract][Full Text] [Related]
77. Dietary Restriction for The Treatment of Meniere's Disease.
De Luca P; Cassandro C; Ralli M; Gioacchini FM; Turchetta R; Orlando MP; Iaccarino I; Cavaliere M; Cassandro E; Scarpa A
Transl Med UniSa; 2020 May; 22():5-9. PubMed ID: 32523900
[TBL] [Abstract][Full Text] [Related]
78. Clinical Practice Guideline: Ménière's Disease Executive Summary.
Basura GJ; Adams ME; Monfared A; Schwartz SR; Antonelli PJ; Burkard R; Bush ML; Bykowski J; Colandrea M; Derebery J; Kelly EA; Kerber KA; Koopman CF; Kuch AA; Marcolini E; McKinnon BJ; Ruckenstein MJ; Valenzuela CV; Vosooney A; Walsh SA; Nnacheta LC; Dhepyasuwan N; Buchanan EM
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):415-434. PubMed ID: 32267820
[TBL] [Abstract][Full Text] [Related]
79. Correlation of Objective Audiometric and Caloric Function in Ménière's Disease.
McMullen KP; Lin C; Harris MS; Adunka OF
Otolaryngol Head Neck Surg; 2017 May; 156(5):912-916. PubMed ID: 28168899
[TBL] [Abstract][Full Text] [Related]
80. EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma.
Yung M; Tono T; Olszewska E; Yamamoto Y; Sudhoff H; Sakagami M; Mulder J; Kojima H; İncesulu A; Trabalzini F; Özgirgin N
J Int Adv Otol; 2017 Apr; 13(1):1-8. PubMed ID: 28059056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
